Robert Fishman

Robert Fishman

No open positions remaining
64 year
Health Technology
Consumer Services
Health Services

Profile

Robert Stephen Fishman worked as Director-Clinical Affairs at Heartport, Inc. from 1995 to 1998.
He then worked as Vice President-Scientific Affairs at Aerogen, Inc. from 1998 to 2005.
From 2005 to 2007, he was Senior Vice President-Clinical Development at Anthera Pharmaceuticals, Inc. He then worked as Vice President-Medical Affairs at Alexza Pharmaceuticals, Inc. from 2007 to 2009.
From 2012 to 2015, he was Senior Vice President-Clinical Development at InterMune, Inc. He worked as Chief Medical Officer at Corcept Therapeutics, Inc. from 2015 to 2019.
He also served as a Trustee at Boca Raton Regional Hospital, Inc. He is currently working as Chief Medical Officer at 4D Molecular Therapeutics, Inc. from 2020 to 2023.
He previously worked as Chief Medical Officer at Xoc Pharmaceuticals, Inc. from 2019 to 2020.
Dr. Fishman received his undergraduate degree from Harvard University and his doctorate from Stanford University School of Medicine.

Former positions of Robert Fishman

CompaniesPositionEnd
4D MOLECULAR THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 13/04/2023
Chief Tech/Sci/R&D Officer 01/10/2020
CORCEPT THERAPEUTICS INCORPORATED Chief Tech/Sci/R&D Officer 31/01/2019
INTERMUNE INC Chief Tech/Sci/R&D Officer 01/03/2015
ANTHERA PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01/01/2007
See the detail of Robert Fishman's experience

Training of Robert Fishman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

51

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Consumer Services

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Robert Fishman
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!